ABOUT SYNGENE INTERNATIONAL
Syngene International Ltd. is an integrated, contract research, development, and manufacturing services company serving the global pharma, biotech, nutrition, animal health, consumer goods, and specialty chemical sectors.
Our Discovery services comprise early-stage research from target identification to delivery of drug candidates for further development. Our Development services encompass activities from pre-clinical to clinical trials including Drug Substance Development (DSP), Drug Product Development (DPD), and associated services to demonstrate safety, tolerability, and efficacy of the selected drug candidate.
Syngene’s Manufacturing services for Small and Large Molecules include cGMP-compliant facilities for clinical supplies, registration batches as well as commercial volumes through our API manufacturing plant and disposable Biologics manufacturing facility.
Our 4500+ scientists have both the skills and the capability to deliver great science, ensure robust data management, IP security, and quality manufacturing at speed to improve time-to-market and lower the cost of innovation.
With 2 Mn sq ft of specialist discovery, development, and manufacturing facilities, Syngene offers dedicated research facilities for Amgen, Baxter, Bristol-Myers Squibb, and Herbalife. We also work with biotech companies pursuing leading-edge science, and MNCs including GSK and Merck KGaA.
Syngene’s state-of-the-art research facilities are ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007 certified. Our animal facilities are GLP certified by Indian authorities, and also AAALAC accredited. Syngene is also India’s only GLP certified (by National GLP Compliance Monitoring Authority Govt. of India) viral clearance service provider.
A strong corporate governance framework focused on client satisfaction, quality, safety, ethics, and integrity, makes us the partner of choice for all research-related services. Currently, we have 400+ active clients across US, Europe, Japan, India, and the rest of the world, with 400+ patents held with clients.